by Cassie Arnold | Jan 28, 2021 | Biotech Finance, Deal making, Digital Health, Digital Therapeutics, Investment
After starting off 2020 with a 35 percent drop in the number of deals from the previous quarter, digital therapeutic deal-making steadily climbed over the course of 2020 to total 71 deals for the year. With 25 deals in the fourth quarter of 2020, the index was up 44...
by Cassie Arnold | Nov 10, 2020 | Biotech Finance, Deal making, Digital Health, Digital Therapeutic
Tired from a long week of parsing electoral college votes? How about focusing on digital therapeutic deals for a change of pace? The third quarter brought a record number of digital therapeutic deals with a total of 19. That’s up from 16 in the previous quarter. The...
by Cassie Arnold | Jul 8, 2020 | Deal making, Digital Health, Digital Therapeutic, Investment
Digital therapeutic dealmaking bounced back to Q4 2019 levels in the second quarter of the year. After a first quarter where deal-making was stymied in by the onslaught of COVID-19, buyers came back big-time in the second quarter once the reality of the “new...
by Cassie Arnold | Apr 21, 2020 | Deal making, Digital Health, Digital Therapeutic, Investment
First quarter digital therapeutic deal data provided by DealForma shows a drop quarter-over-quarter from 16 transactions in the last quarter of 2019 to 11 in the first quarter of 2020. But year-over-year, the first quarter of 2020 is on par with the first quarter of...
by Cassie Arnold | Feb 25, 2020 | Biotech Finance, Digital Health, Digital Therapeutic
When I started following the digital health sector in earnest about ten years ago, I was intrigued with the potential of digital technology to treat disease – the so-called digital therapeutics. Instead, the sector produced an almost infinite variety of activity...
